Stachestrong Raises $340,000 For The Ivy Brain Tumor Center’S Innovative Phase 0 Clinical Trial Of Sonodynamic Therapy For Patients With Glioblastoma
Stachestrong Raises $340,000 For The Ivy Brain Tumor Center’S Innovative Phase 0 Clinical Trial Of Sonodynamic Therapy For Patients With Glioblastoma
12/01/21, 1:08 PM
Money raised
$340,000
Round Type
seed
StacheStrong, a non-profit devoted to raising funds and awareness for brain cancer research, and Barrow Neurological Foundation, announced they raised $340,000 for the Ivy Brain Tumor Center at Barrow Neurological Institute. The funds will go towards the Ivy Center’s first-in-human Phase 0/1 clinical trial of sonodynamic therapy for patients with recurrent glioblastoma multiforme and recurrent high-grade gliomas.